First Chikungunya Case in Spain is Reported to WHO

Article

On Aug. 3, 2015, the World Health Organization (WHO) was notified by the National IHR Focal Point for Spain of a case of chikungunya infection in the city of Gandia, Valencian Community. This is the first time that an individual with no history of travel to a chikungunya-endemic area tests positive for the disease in Spain.

The patient is a 60-year-old man. He developed symptoms on July 7 in France and sought medical care on July 8 while still in France. Following his return to Spain, the patient was hospitalized on July 11 and discharged on July 16. Patient blood samples were collected on July 23. On July 31, he was laboratory confirmed to be positive for chikungunya by identification of IgM in serum by ELISA testing. During his probable incubation period and while symptomatic – this is the period when a patient can acquire the infection and transmit it to others – the patient stayed in the Valencian Community, Spain and in the Languedoc-Roussillon region, France where the competent vector Aedes albopictus has been shown to be present.

Spanish health authorities are carrying out epidemiological and entomological investigations as well as establishing vector control measures. National health authorities in France have informed local health authorities, which are implementing vector control activities in the areas visited by the patient.

WHO encourages countries to develop and maintain the clinical and laboratory capacity to detect and confirm cases, manage patients and implement social communication strategies to engage the community in reducing the presence of the mosquito vectors.

Source: WHO

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)